Eaton Vance Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-58
Closed 2793
2021
Q4
$0 Hold
58
﹤0.01% 2893
2021
Q3
$1K Hold
58
﹤0.01% 1978
2021
Q2
$1K Hold
58
﹤0.01% 2782
2021
Q1
$1K Buy
+58
New +$975 ﹤0.01% 2862

Other funds holding LUMO

Eaton Vance Management's LUMO Position: Q1 2022 in Review

Eaton Vance Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q1 2022, closing a stake of 58 shares.

Eaton Vance Management first reported a position in LUMO in Q1 2021 and held it in 4 quarters. The position peaked at $1K in Q3 2021. 36 funds tracked by Wall St. Rank hold LUMO as of Q1 2022.

  • Eaton Vance Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Eaton Vance Management sold 58 Lumos Pharma, Inc. Common Stock shares in Q1 2022.
  • Eaton Vance Management first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2021 and held it in 4 quarters.
  • Eaton Vance Management's Lumos Pharma, Inc. Common Stock position peaked at $1K in Q3 2021.
  • 36 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q1 2022.

Based on Eaton Vance Management's 13F filing for Q1 2022, filed 16 May 2022.